Arthur D Riggs

This inventor holds 23 USPTO granted patents and 6 published patent applications, plus 2 CIPO patents and 2 EPO patents, primarily in Antibody Development. Top assignees: Beckman Research Institute, City of Hope, Genentech, Inc.. Active years: 1982-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arthur D Riggs. Retrieved from https://idiyas.com/inventor/arthur-d-riggs

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 23 (Patent Applications = 6)

% Patents Active = 91.3

CIPO Patents = 2 (Patent Applications = 1)

EPO Patents = 2 (Patent Applications = 1)

Average Co-Inventor Count = 2.0

ph-index = 14

Forward Citations = 5,982(Granted Patents)

Company Filing History:

12 out of 692

Beckman Research Institute, City of Hope

where one patent can have more than one assignee

Years Active: 1982-2026

Loading Chart...

Areas of Expertise:

Antibodies

Immunoglobulins

Chimeric Antibodies

Microbial Expression

Cytomegalovirus

Polypeptide Expression

RNA Binding Sites

Somatostatin Conjugates

Recombinant Cloning

Heavy Chains

Light Chains

Transformant Culture

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12617845 - SMC1A ANTIBODIES AND USES THEREOF (2026-05-05),

2. 7923221 - Methods of making antibody heavy and light chains having specificity for a desired antigen (2011-04-12),

3. 7238480 - Pyrophosphorolysis activated polymerization (PAP) (2007-07-03),

4. 7083926 - Method for identifying accessible binding sites on RNA (2006-08-01),

5. 7033763 - Pyrophosphorolysis activated polymerization (PAP) (2006-04-25),

6. 6562570 - Method for identifying accessible binding sites on RNA (2003-05-13),

7. 6331415 - Methods of producing immunoglobulins, vectors and transformed host cells for use therein (2001-12-18),

8. 6242567 - Method for detection and prevention of human cytomegalovirus infection (2001-06-05),

9. 6133433 - Method for detection and prevention of human cytomegalovirus infection (2000-10-17),

10. 5583013 - Method and means for microbial polypeptide expression (1996-12-10),

11. 5420020 - Method and means for microbial polypeptide expression (1995-05-30),

12. 5270183 - Device and method for the automated cycling of solutions between two or (1993-12-14),

13. 5221619 - Method and means for microbial polypeptide expression (1993-06-22),

14. 5081235 - Chimeric anti-CEA antibody (1992-01-14),

15. 5075431 - Chimeric anti-CEA antibody (1991-12-24),

Title: Arthur D. Riggs: A Pioneer in Biotech Innovations

Introduction

Arthur D. Riggs, an accomplished inventor based in La Verne, California, holds an impressive portfolio of 22 patents. His work primarily focuses on biotechnological advancements, particularly in the fields of immunology and genetic engineering. Riggs' innovative contributions have significantly influenced the biotech industry, paving the way for new therapies and diagnostic methods.

Latest Patents

Among his latest patents, Riggs has developed methods for producing antibody heavy and light chains that exhibit specificity for desired antigens. This invention involves processes that utilize vectors to produce immunoglobulin heavy and light chains within a single cell. Additionally, his patent on pyrophosphorolysis activated polymerization (PAP) presents a novel technique that combines pyrophosphorolysis and DNA polymerization for enhanced amplification of DNA. This method significantly improves the specificity in detecting rare mutant alleles amidst wild-type alleles, showcasing his ingenuity in addressing complex biological challenges.

Career Highlights

Throughout his career, Arthur D. Riggs has made significant strides in the biotech space, working with notable companies such as Genentech, Inc. and City of Hope. His work has not only led to numerous patents but has also contributed to transformative developments in therapeutic and diagnostic applications.

Collaborations

Riggs has collaborated with prominent figures in the field, including Shmuel Cabilly and Herbert L. Heyneker. These partnerships have furthered his research and brought about innovative solutions in immunology and genetic engineering.

Conclusion

Arthur D. Riggs stands out as a leading inventor in the biotechnology sector, whose contributions continue to inspire advancements in medical science. His extensive patent portfolio, marked by groundbreaking inventions, underscores his role in shaping the future of biotechnological innovations.

Profile summary based on public USPTO records.